32Janssen Research & Development ▲ Sign in to save

• ▲ Emilie M.J. van Brummelen

  Johnson & Johnson (Netherlands) Medicine
  4.84k

  citations

  22

  h-index

  26

  Aachen papers
• ▲ Carla J. de Boer

  Medicine
  3k

  citations

  18

  h-index

  6

  Aachen papers

2 results

• Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Vrd Alone in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Eligible for Autologous Stem Cell Transplantation (ASCT): Primary Results of the Perseus Trial

  2023 Blood article Medicine Multiple Myeloma Research and Treatments Open access

  18

  citations
• Health-Related Quality of Life in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Data from the Perseus Trial of Subcutaneous Daratumumab Combined with Bortezomib, Lenalidomide, and Dexamethasone (D-VRd)

  2024 Blood conference-abstract Medicine Multiple Myeloma Research and Treatments Open access

  1

  citations

2 results